Abstract:It is thought that ablative radiotherapy (RT), used for rapid control tumor growth, induces genotoxic stress and mitosis crisis leading to prolonged dormancy of irradiated tumor at local and distal site in most patients. We have unexpectedly observed that initial reduction of tumor burden following ablative RT also depends largely on type I IFN for CTL. Targeting tumor with IFN can control tumor growth through initiating a coordinated innate and adaptive immune attack against tumor cells. However, the mechanism for radiation-mediated type I IFN induction remains unclear. Here, we demonstrated that STING, but not MYD88, was required for type I IFN-dependent antitumor effects of radiation. STING in dendritic cells (DCs) controlled radiation-mediated IFN-β induction and was activated by irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS) mediated DCs sensing of irradiated-tumor cells. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-β treatment rescued cGAS/STING-deficient immune responses. Accordingly, enhancing STING signaling by cGAMP administration promoted antitumor efficacy of radiation. Our results reveal that the molecular mechanism of radiation-mediated antitumor immunity depends on a proper cytosolic DNA-sensing pathway, pointing towards a new understanding of radiation and host interactions. Furthermore, we uncover a new strategy to improve radiotherapy by cGAMP treatment. RT induced IFN can also upregulate PD-L1 that suppress T cell-mediated damage and develop radiation resistance for relapse over time. Anti-PDL-1 antibody can greatly reduce radiation resistance leading to complete tumor regression. Furthermore, our study challenges the rationale for current radio/chemotherapy strategies and highlights the importance of immune activation in preventing tumor relapse. Citation Format: Yang-xin Fu. Radiation-mediated DNA sensing pathway for immunity and tumor regression. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr SY39-03. doi:10.1158/1538-7445.AM2015-SY39-03

From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy

From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Radiation-Mediated Dna Sensing Pathway For Immunity And Tumor Regression

Abstract SY39-03: Radiation-mediated DNA Sensing Pathway for Immunity and Tumor Regression

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy

Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy

The Intersection of Radiotherapy and Immunotherapy: Mechanisms and Clinical Implications.

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

The immunological consequences of radiation-induced DNA damage

Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness

The Efficacy of Radiotherapy Relies Upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity.

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy

Harnessing The Targeting Potential Of Differential Radiobiological Effects Of Photon Versus Particle Radiation For Cancer Treatment

The Cellular Response to Complex DNA Damage Induced by Ionising Radiation

The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy

Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches